Eagle Bay Advisors LLC Amgen Inc Transaction History

Eagle Bay Advisors LLC

$170 Million
Q3 2024

A detailed history of Eagle Bay Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Eagle Bay Advisors LLC holds 1,224 shares of AMGN stock, worth $359,856. This represents 0.23% of its overall portfolio holdings.

Number of Shares

1,224

Previous 1,243 1.53%

Holding current value

$359,856

Previous $388,000 1.55%

% of portfolio

0.23%

Previous 0.24%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	SELL	$309.38 - $337.38 $5,878 - $6,410	-19 Reduced 1.53%	1,224 $394,000
Q2 2024 Jul 26, 2024	BUY	$262.75 - $319.31 $72,519 - $88,129	276 Added 28.54%	1,243 $388,000
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $54,580 - $65,885	-203 Reduced 17.35%	967 $274,000
Q4 2023 Feb 08, 2024	SELL	$255.7 - $288.46 $148,306 - $167,306	-580 Reduced 33.14%	1,170 $336,000
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $60,347 - $74,922	276 Added 18.72%	1,750 $470,000
Q2 2023 Aug 10, 2023	SELL	$214.27 - $253.37 $51,210 - $60,555	-239 Reduced 13.95%	1,474 $327,000
Q1 2023 Apr 24, 2023	SELL	$225.79 - $275.2 $45,609 - $55,590	-202 Reduced 10.55%	1,713 $414,000
Q4 2022 Jan 26, 2023	SELL	$229.03 - $291.01 $117,263 - $148,997	-512 Reduced 21.1%	1,915 $0
Q3 2022 Nov 22, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 0.04%	2,427 $547,000
Q2 2022 Aug 19, 2022	BUY	$230.71 - $256.74 $157,574 - $175,353	683 Added 39.19%	2,426 $590 Million
Q1 2022 May 11, 2022	SELL	$219.27 - $242.57 $14,691 - $16,252	-67 Reduced 3.7%	1,743 $422,000
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $132,056 - $151,126	-664 Reduced 26.84%	1,810 $397,000
Q3 2021 Nov 12, 2021	BUY	$212.27 - $248.7 $278,073 - $325,797	1,310 Added 112.54%	2,474 $528,000
Q2 2021 Jul 30, 2021	BUY	$233.58 - $259.14 $271,887 - $301,638	1,164 New	1,164 $288,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Bay Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Bay Advisors LLC with notifications on news.

Account

Eagle Bay Advisors LLC Amgen Inc Transaction History